SevenOneSeven Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-805
| Closed | -$272K | – | 54 |
|
2023
Q3 | $272K | Buy |
805
+25
| +3% | +$8.45K | 0.63% | 38 |
|
2023
Q2 | $308K | Sell |
780
-2
| -0.3% | -$789 | 0.69% | 29 |
|
2023
Q1 | $282K | Sell |
782
-358
| -31% | -$129K | 0.63% | 26 |
|
2022
Q4 | $268K | Buy |
1,140
+105
| +10% | +$24.7K | 0.58% | 46 |
|
2022
Q3 | $255K | Buy |
1,035
+29
| +3% | +$7.15K | 0.6% | 39 |
|
2022
Q2 | $304K | Buy |
1,006
+21
| +2% | +$6.35K | 0.71% | 34 |
|
2022
Q1 | $405K | Buy |
985
+1
| +0.1% | +$411 | 0.84% | 33 |
|
2021
Q4 | $462K | Buy |
984
+120
| +14% | +$56.3K | 0.91% | 29 |
|
2021
Q3 | $367K | Buy |
864
+14
| +2% | +$5.95K | 0.93% | 28 |
|
2021
Q2 | $305K | Buy |
850
+95
| +13% | +$34.1K | 0.79% | 37 |
|
2021
Q1 | $213K | Buy |
+755
| New | +$213K | 0.78% | 42 |
|